Chen, StephanieMiravitlles, MarcRhee, Chin KookPavord, Ian D.Jones, RupertCarter, VictoriaEmmanuel, BenjaminAlacqua, MariannaPrice, David2022-09-092022-09-092022-09-09Chen, S, Miravitlles, M, Rhee, C K, Pavord, I D, Jones, R, Carter, V, Emmanuel, B, Alacqua, M & Price, D 2022, 'Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy', International journal of chronic obstructive pulmonary disease , vol. 2022, no. 17, pp. 2187—2200. https://doi.org/10.2147/COPD.S3786491176-9106https://hdl.handle.net/2164/19154Acknowledgments This work uses data provided by patients and collected by the National Health Service as part of their care and support. Medical writing and editorial support were provided by Jennifer Gibson, PharmD, and Leonard Lionnet, PhD, of Kay Square Scientific, LLC. This support was funded by AstraZeneca. FUNDING This study was funded by AstraZeneca.145229471engchronic obstructive pulmonary diseasedisease burdeneosinophilsexacerbationshealth care resource utilizationR MedicineRJournal article10.2147/COPD.S37864917